CASRAI Dictionary

Tag: research misconduct guidelines

  • Famous Cases of Research Misconduct in India: Building Investigation Capacity

    India has produced a long run of documented research misconduct cases — plagiarism by university vice-chancellors, data manipulation at premier institutes, and mass retractions from the Indian Institutes of Technology (IITs) — because the country has no statutory equivalent of the US Office of Research Integrity. Since 2018, that gap has started closing through UGC regulations, an ICMR ethics policy, and India’s first dedicated Research Integrity Office, opened in Bengaluru in 2022.

    Research misconduct is the fabrication, falsification, or plagiarism of data or authorship in proposing, performing, or reviewing research, or in reporting research results. In India, the term also commonly extends to duplicate (“self-plagiarism”) publication and fraudulent peer review, both of which feature heavily in the country’s retraction record.

    This article sets out the famous cases of research misconduct in india that shaped public and regulatory attention, then examines — in more depth than the case lists alone provide — the specific institutional mechanisms India has built since 2018 to investigate and deter misconduct, benchmarked against the UK’s comparable framework.

    What is research misconduct, and how common is it in India?

    Research misconduct covers fabrication, falsification, plagiarism, and — in India’s documented record — duplicate publication and compromised peer review. India does not operate a statutory oversight body comparable to the US Office of Research Integrity, so cases are typically investigated on an ad-hoc basis by institutional committees, independent enquiry panels, or journal editors, often only after a public complaint or media report triggers action.

    Retraction volume gives a rough proxy for scale. An analysis by the volunteer watchdog Indian Research Watch (IRW), drawing on the Retraction Watch database, found that 58 papers authored or co-authored by faculty across 12 of India’s 23 IITs were retracted for plagiarism or duplicate publication between 2006 and 2023 — compared with three retractions from Stanford, two from Princeton, five from Oxford, five from Cambridge, and ten from Tsinghua over the same period. IRW also recorded a 2.5-fold surge in Indian institutional retractions in 2020–2022 compared with 2017–2019.

    Which cases shaped India’s research misconduct record?

    A handful of cases became reference points for how India investigates — and fails to investigate — misconduct allegations.

    • B.S. Rajput, Kumaon University (2002–2003): the vice-chancellor was accused by Indian and international physicists, including a Nobel laureate co-signatory, of plagiarising a paper from a Stanford researcher. A committee led by retired judge Justice S.R. Singh upheld the charge in February 2003, and Rajput resigned immediately.
    • Gopal Kundu, National Centre for Cell Science, Pune (2006–2010): an anonymous complaint alleged data misrepresentation in a Journal of Biological Chemistry paper. The journal withdrew the paper in 2007, and the Indian Academy of Sciences barred Kundu from its activities for three years following an internal ethics review in 2010.
    • Ashok Kumar, IIT Kanpur (2010): two review articles in Biotechnology Advances were retracted for extensive copying, prompting the Society for Scientific Values to publicly reprimand several IITs over lax plagiarism handling that year.
    • P. Chiranjeevi, Sri Venkateswara University (2004–2008): a chemistry professor was found to have plagiarised content across roughly 70 papers; the university barred him from examination duties, research guidance, and further promotion.
    • Sanjeeb Kumar Sahoo, Institute of Life Sciences, Bhubaneswar (2013): five papers in Acta Biomaterialia were retracted for serial self-plagiarism, data manipulation, and falsification of results.

    These cases share a pattern: detection came from external whistleblowers, journal editors, or watchdog groups rather than routine institutional audit — the exact gap India’s newer capacity-building measures target.

    How are Indian institutions building investigation capacity?

    Since 2018, national regulators and individual institutions have begun replacing ad-hoc responses with defined procedures, though implementation remains uneven across India’s roughly 1,000-plus universities.

    • UGC (Promotion of Academic Integrity and Prevention of Plagiarism in Higher Educational Institutions) Regulations, 2018: the University Grants Commission’s regulation defines plagiarism thresholds by similarity-index band and prescribes tiered penalties, from reworking a manuscript to debarment from supervising research.
    • Mandatory Research and Publication Ethics (RPE) training: UGC rules require a two-credit RPE course for all PhD scholars, intended to instil ethical practice before misconduct occurs rather than only punishing it afterward.
    • UGC-CARE (Consortium for Academic and Research Ethics): maintains a vetted journal list to steer researchers away from predatory publications that facilitate low-scrutiny misconduct.
    • ICMR research integrity policy: the Indian Council of Medical Research has its own publication-ethics and research-integrity policy governing biomedical research, alongside its National Ethical Guidelines for Biomedical and Health Research.
    • India’s first dedicated Research Integrity Office: in 2022, the Institute for Stem Cell Science and Regenerative Medicine (inStem) and the National Centre for Biological Sciences (NCBS) in Bengaluru jointly established India’s first standing Research Integrity Office, tasked with policy-setting, data archiving, training, and case investigation — a structural model still rare outside this campus.
    • Independent watchdogs: the Society for Scientific Values, active since the 1980s, and Indian Research Watch, founded in 2022 by data scientist Achal Agrawal, continue to supply the external scrutiny that formal bodies have not yet fully absorbed.

    How does India’s framework compare with the UK’s?

    The UK’s research misconduct architecture is older and more codified, offering a useful benchmark for what a mature system looks like once statutory pressure and funder mandates are added.

    Feature India United Kingdom
    Core guidance document UGC 2018 Regulations; ICMR research integrity policy Universities UK Concordat to Support Research Integrity (2019 revision)
    Statutory oversight body None — no equivalent to the US Office of Research Integrity None — UK Research Integrity Office (UKRIO) is advisory, not statutory
    Institutional requirement Ethics/misconduct committees, variably implemented Named research integrity lead plus an annual public statement to funders
    Investigation trigger Usually a whistleblower complaint or media report Defined internal procedure for the investigation of misconduct in research, often COPE-aligned, with escalation routes to funders

    The comparison shows India’s 2018–2022 reforms following a similar path the UK walked earlier — moving from voluntary good practice toward named responsibility and funder-linked reporting — but roughly a decade behind in institutional coverage.

    Frequently asked questions

    What are some examples of research misconduct?

    Fabrication, falsification, and plagiarism are the three core categories recognised internationally. In India’s record, this has manifested as copied text and images, manipulated western blot data, duplicate (“self-plagiarised”) publication, and fraudulent peer review used to fast-track weak manuscripts into print.

    What are the 5 unethical practices in research?

    The five widely cited categories are falsification of data, failure to credit others, plagiarism, conflicts of interest, and biased design or interpretation driven by outside influence. Indian cases documented above illustrate the first three most frequently, particularly plagiarism and data falsification.

    What are the implications for institutions, publishers, and funders?

    For Indian institutions, the direction is toward standing capacity rather than reactive committees: named integrity offices, mandatory ethics training, and journal-quality filtering via UGC-CARE. For international publishers and funders working with Indian co-authors, the retraction data signal a need for stronger pre-publication screening rather than reliance on post-hoc whistleblowing. For research administrators globally, India’s experience underscores a broader lesson also visible in research administration practice elsewhere: investigation procedures only function once an institution has a named owner, a documented process, and independence from the department under review.

    Conclusion: the road ahead

    India’s famous research misconduct cases exposed a structural gap: no statutory body, uneven institutional follow-through, and detection driven mostly by outsiders. The 2018 UGC regulations, ICMR’s integrity policy, mandatory RPE training, and the 2022 inStem/NCBS Research Integrity Office mark a genuine shift toward standing investigation capacity. Whether that capacity scales beyond a handful of leading institutions to India’s broader university system remains the open question for the next decade.

  • Duke Research Misconduct Policy vs MIT, Stanford

    Duke, MIT and Stanford each operationalise the same federal research-misconduct standard through different institutional machinery. Duke routes allegations to a Misconduct Review Officer and a 24-hour Integrity Line; MIT centralises review under its Vice President for Research; Stanford assigns first-line assessment to school deans under a Research Policy Handbook chapter revised effective 1 January 2026. All three exist to satisfy one governing rule: the Public Health Service Policy on Research Misconduct.

    The federal policy on research misconduct — codified at 42 C.F.R. Part 93 and enforced by the HHS Office of Research Integrity (ORI) — defines research misconduct as fabrication, falsification, or plagiarism (FFP) in proposing, performing, or reviewing research, or in reporting research results. Every US university that accepts Public Health Service funding, including Duke, MIT and Stanford, must maintain an institutional policy that meets this baseline, then layers its own governance, reporting channels, and disciplinary structure on top.

    How does Duke’s research misconduct policy define and handle allegations?

    Duke’s research misconduct policy is set out in the Duke University Policy and Procedures Governing Misconduct in Research, part of the Faculty Handbook and last updated in May 2023. Allegations are directed to a designated Misconduct Review Officer (MRO), or to a department chair, division chief, or dean, who must promptly forward the matter to the MRO.

    Duke also operates an Integrity Line — a 24-hour, anonymous telephone hotline (1-800-826-8109) — so that reporters can raise concerns without disclosing their identity. This dual-channel design (a named institutional officer plus an anonymous hotline) reflects a broader reform effort: Duke’s policy was revised to extend coverage beyond faculty to research staff, alongside wider research-integrity reforms following a 2019 case in which the university agreed to a $112.5 million False Claims Act settlement over fabricated data in federally funded pulmonary research, as reported by Science. That episode is a documented driver of the university folding staff explicitly into the policy’s scope, according to case-study materials prepared for the Council on Governmental Relations (COGR).

    How does MIT structure its research misconduct procedures?

    MIT’s framework sits in MIT Policies and Procedures §10.1, “Procedures for Dealing with Misconduct in Research and Scholarship,” last updated 10 December 2025. Oversight is centralised: every allegation, wherever it is first raised, must be conveyed promptly to the Vice President for Research (VPR), MIT’s designated Research Integrity Officer.

    MIT’s definition tracks the federal FFP triad — fabrication (making up data), falsification (manipulating materials or altering results), and plagiarism (appropriating another’s ideas or words without credit) — but adds a fourth category not found in the core PHS definition: deliberate interference, meaning intentionally causing material harm to another’s research, such as damaging equipment or deleting data. MIT’s policy also explicitly excludes self-plagiarism (text recycling) and authorship or credit disputes among former collaborators from the definition of misconduct, mirroring longstanding ORI guidance on plagiarism.

    What changed in Stanford’s research misconduct policy for 2026?

    Stanford’s governing chapter, Research Policy Handbook (RPH) 1.7, “Research Misconduct: Policy on Allegations, Investigations, and Reporting,” dates originally to 3 February 1983 but carries a current version effective 1 January 2026. The update aligns Stanford’s procedures with the 2024 Final Rule amending 42 C.F.R. Part 93 — the same federal regulation that governs Duke and MIT.

    Two provisions distinguish Stanford’s approach. First, the “Six-Year Rule” (42 C.F.R. §93.104): research misconduct allegations are only actionable if the conduct occurred within six years of the date Stanford or a federal agency received the allegation, subject to a “subsequent use” exception (if the respondent later cited or republished the disputed material) and a “public health and safety” exception. Second, first-line responsibility sits with the school dean, who must assess an allegation and, if it meets the definition, immediately open an inquiry and notify the Dean of Research — a more devolved structure than MIT’s single VPR intake point.

    How do Duke, MIT and Stanford compare side by side?

    The table below sets the three institutional policies against each other and against the federal baseline they all must satisfy.

    Institution Governing document First-line authority Reporting channel Misconduct definition
    Duke University Policy and Procedures Governing Misconduct in Research (Faculty Handbook, updated May 2023) Misconduct Review Officer MRO, department chair/dean, or anonymous Integrity Line FFP, per 42 C.F.R. Part 93; covers faculty and staff
    MIT MIT Policies and Procedures §10.1 (updated 10 Dec 2025) Vice President for Research Report to VPR, typically via supervisor or department head FFP plus deliberate interference; excludes self-plagiarism and authorship disputes
    Stanford University Research Policy Handbook 1.7 (current version 1 Jan 2026; original 1983) School dean, then Dean of Research Report to school dean for initial assessment FFP per 42 C.F.R. Part 93 (2024 Final Rule); six-year time limitation
    Federal baseline PHS Policy on Research Misconduct, 42 C.F.R. Part 93 HHS Office of Research Integrity (ORI) Institutional report to ORI after a finding Fabrication, falsification, or plagiarism (FFP)

    All three institutions converge on the same two-stage process required by federal policy:

    • An inquiry — a preliminary assessment of whether an allegation has substance and warrants formal review.
    • An investigation — a full evidentiary examination that produces findings reported to ORI when federal funding is involved.

    Common questions on federal and institutional research misconduct policy

    What is the US federal research misconduct policy?

    The US federal research misconduct policy is the Public Health Service Policy on Research Misconduct, codified at 42 C.F.R. Part 93 and enforced by ORI. It applies to fabrication, falsification, and plagiarism in proposing, performing, reviewing, or reporting PHS-supported research, and requires every recipient institution to maintain a compliant local policy.

    What is 42 CFR Part 93 research misconduct?

    42 C.F.R. Part 93 is the federal regulation setting the definitions, procedural standards, and reporting obligations that PHS-funded institutions — including Duke, MIT, and Stanford — must follow. A 2024 Final Rule to Part 93 took effect on 1 January 2026, updating provisions including the definition of plagiarism that institutions must now apply.

    What are the three types of research misconduct?

    The three federally recognised types are fabrication (inventing data or results), falsification (manipulating materials, equipment, or data so the research record is inaccurate), and plagiarism (using another’s ideas, processes, or words without credit). Honest error and legitimate differences of scientific opinion are explicitly excluded.

    What constitutes research misconduct according to federal regulations?

    A federal finding requires three elements together: a significant departure from accepted research practices, conduct committed intentionally, knowingly, or recklessly, and an allegation proven by a preponderance of the evidence. All three tests must be met before ORI or an institution can record a formal finding of misconduct.

    What this means for research administrators

    For research administrators, compliance officers, and institutional leaders, the practical lesson is that federal alignment does not mean procedural uniformity. Duke, MIT, and Stanford each satisfy 42 C.F.R. Part 93, yet route allegations through different first-line authorities — an MRO, a VPR, and a school dean respectively — and set different scope boundaries around staff coverage, deliberate interference, and time limitations. Institutions benchmarking their own research administration policy against peer practice should treat the federal rule as the floor, not the template, and expect further local revisions as the 2024 Final Rule to Part 93 continues to work through university policy cycles into 2026 and beyond.

    Given that Stanford’s update took effect only this year and MIT revised its procedures in December 2025, institutional research misconduct policies are clearly still catching up to the federal 2024 Final Rule — administrators reviewing their own institution’s policy should confirm which version of 42 C.F.R. Part 93 it currently cites before assuming compliance.

  • Retraction Statement: 5 Elements COPE Requires

    A retraction statement must identify the article and its authors, state the specific reason for retraction, name who initiated it, record whether authors agree, and be permanently and bidirectionally linked to the original publication. These five elements come from the Committee on Publication Ethics (COPE) Retraction Guidelines and the NISO Recommended Practice for Communication of Retractions, Removals, and Expressions of Concern (CREC, RP-45-2024). A retraction statement is the formal notice, issued by a journal editor or publisher, that withdraws confidence in a previously published article’s findings while keeping the original text permanently accessible and marked as retracted.

    This guide is a drafting walkthrough, not a policy overview — it maps what COPE decides, what NISO’s CREC standard requires you to structure, and what EASE’s checklist helps you verify, into a single sequence editors and research-integrity offices can follow when a retraction notice actually has to go out.

    What must a retraction statement include?

    A compliant retraction statement combines a governance decision with a metadata obligation. COPE’s Retraction Guidelines set out when and why a retraction should happen; the NISO CREC Recommended Practice, published in June 2024, sets out how that decision must be communicated so it propagates reliably across databases, citation managers and search indexes. Combining both frameworks gives five required elements.

    # Element Source requirement
    1 Full identification of the retracted article (title, authors, DOI, citation) COPE Retraction Guidelines (2019)
    2 A specific, factual reason for retraction, distinguishing honest error from misconduct COPE Retraction Guidelines; NISO RP-45-2024
    3 Identification of who initiated the retraction (authors, editor, institution, publisher) COPE Retraction Guidelines
    4 Documented author agreement or disagreement with the decision COPE Retraction Guidelines
    5 Bidirectional, machine-readable linking between notice and original, with prompt free access NISO RP-45-2024 (CREC); COPE

    The original article is never deleted. Under COPE’s guidance it must remain online, clearly watermarked as retracted on every page of the PDF, with the retraction notice linked in both directions so readers encountering either document see the other. The EASE Standardised Retraction Form operationalises this as a checklist editors can complete before publication of the notice, reducing the inconsistency that COPE and NISO both identify as a persistent weakness in current practice.

    How do you document the reason for retraction?

    The reason section is where most retraction statements fail. A retraction statement must state, in unambiguous language, which specific data, figures or conclusions are affected and why — not merely that “errors were found.” Vague or reason-free notices deny authors the chance to explain honest mistakes and, per research cited in publisher guidance on this subject, remove the deterrent effect a clear misconduct finding is meant to provide.

    In practice, reasons cluster into recurring categories that function as informal reason codes across journals:

    • Honest error (calculation, methodological or reagent mistakes)
    • Data fabrication or falsification
    • Image or figure manipulation or duplication
    • Plagiarism or duplicate/overlapping publication
    • Ethical violations (consent, animal welfare, authorship disputes)
    • Irreproducibility discovered post-publication

    Plagiarism and data manipulation remain the most frequently cited categories in large-scale retraction analyses, and Nature reported that more than 10,000 research papers were retracted in 2023 alone — a record volume that intensified pressure on journals to standardise how reasons are recorded rather than merely disclosed. Where an institutional investigation produced the finding, the statement should attribute it directly to that body rather than restating it as the editor’s own conclusion.

    Who signs off on a retraction statement?

    Under COPE guidelines, the editor holds final authority to retract, but authors retain the right to have their agreement or disagreement recorded in the published notice. This is not a formality: a notice that silently presents unanimous agreement when one co-author disputed the decision misrepresents the record and can itself become a subject of complaint.

    Three sign-off outcomes are possible, and the statement should say plainly which applies:

    • Full agreement — all authors accept the retraction and its stated reason.
    • Partial agreement — some authors agree; named dissenting authors are recorded with their position.
    • Editor-initiated without author agreement — used when authors are unreachable, uncooperative, or contest findings the editor and, where applicable, the institution consider conclusive.

    Because contributor-level disputes often drive disagreement over sign-off, journals increasingly ask retracting authors to clarify individual contributions during the process — a task that structured contributor role taxonomies support. CASRAI originated the CRediT contributor role taxonomy in 2014; the standard is now stewarded by NISO as ANSI/NISO Z39.104-2022 and is widely used to attribute exactly whose CRediT contributor role is implicated when a retraction turns on data curation, analysis or investigation responsibilities rather than the paper as a whole. Research-integrity offices handling authorship disputes alongside a retraction should document this separately from the notice itself.

    How should a retraction be linked and communicated?

    NISO’s CREC Recommended Practice requires that retraction status be carried as structured, machine-readable metadata, not just prose in a PDF — so that discovery layers, citation managers and indexing services display the retraction consistently wherever the article appears, not only on the publisher’s own platform. This closes a long-documented gap: readers who encounter a retracted paper via a secondary database, preprint mirror or reference manager have often seen no retraction indicator at all.

    Practical requirements drawn from CREC and COPE together include:

    • Publishing the notice promptly and making it freely accessible, regardless of the original article’s access status
    • Applying a persistent, visible watermark to every page of the retracted PDF
    • Linking the notice and the original article bidirectionally via persistent identifiers (DOI)
    • Propagating retraction status to abstracting and indexing services and reference-linking systems
    • Retaining the retracted article permanently in the archive rather than removing it

    Retraction Watch’s database independently tracks whether these obligations are actually met, and its long-running “ideal retraction notice” analysis remains a useful benchmark precisely because so many notices still omit the reason, the initiator, or the sign-off status that COPE and NISO both specify.

    Common questions about retraction statements

    What is a retraction notice?

    A retraction notice is the published statement announcing that a journal article’s findings can no longer be relied upon. It is linked to the original article, states the reason, and remains permanently in the record — the article itself is marked as retracted, not deleted.

    What are the most common reasons for retraction?

    Large-scale analyses consistently rank plagiarism, data fabrication or falsification, and image or figure manipulation as the leading causes, followed by honest error and duplicate publication. Reason categories should always be stated explicitly rather than left generic.

    Do retracted studies still get cited?

    Yes. Published citation-tracking studies show retracted papers continue to be cited for years afterward, often because citing authors are unaware of the retraction. This is the core problem the NISO CREC standard’s machine-readable metadata requirement is designed to reduce.

    Can a retracted paper be republished?

    Under COPE’s position on this question, authors may republish reliable portions of a retracted work, provided they transparently notify the new journal’s editors of the prior retraction and its reason. Silent resubmission of retracted material is treated as a fresh ethics violation.

    What this means for editors and institutions

    Retraction volume is rising, not falling: Nature’s 2023 count of over 10,000 retractions was described by integrity researchers as “the tip of the iceberg,” reflecting better detection tools rather than worse research. That trajectory makes standardisation, not case-by-case drafting, the sustainable path for editorial offices and university research-integrity units alike.

    Editors who adopt the COPE-plus-CREC sequence — decide, document the reason, record sign-off, publish with persistent linked metadata — produce notices that hold up under later scrutiny from Retraction Watch, institutional auditors, and the authors themselves. Research-administration offices building or reviewing their own research-administration retraction workflow should treat the EASE form as the pre-publication check and NISO RP-45-2024 as the technical specification the published notice must satisfy.